Valacyclovir
Valacyclovir is a pharmaceutical drug with 66 clinical trials. Currently 5 active trials ongoing. Historical success rate of 90.7%.
Success Metrics
Based on 49 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
25
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
49 of 56 finished
12.5%
7 ended early
5
trials recruiting
66
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Neonatal Phase 1 Valacyclovir Study
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Clinical Trials (66)
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Neonatal Phase 1 Valacyclovir Study
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
Anti-viral Therapy in Alzheimer's Disease
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Valacyclovir in Neonatal Herpes Simplex Virus Disease
Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
Valacyclovir 1000 mg Tablet Under Fed Conditions
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 66